Hims & Hers Health, Inc. officer Soleil Boughton filed a Form 144 notice on October 28, 2026, proposing to sell 3,462 Class A shares of the company through Fidelity Brokerage Services LLC on NYSE.

Key Highlights

  • Proposed sale: Boughton notified the SEC of a plan to sell 3,462 Class A shares with an aggregate market value of $95,551.20.
  • Source of shares: The shares were acquired on August 15, 2026, through restricted stock vesting from the issuer, recorded as compensation.
  • Broker: Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, Rhode Island, is named as the broker for the proposed sale.
  • 10b5-1 plan: The filing indicates a Rule 10b5-1 trading plan was adopted on May 21, 2026.
  • Prior sales disclosed: Five separate Class A share sales by Boughton were reported over the preceding three months, with dates ranging from August 19, 2026, through October 14, 2026.
  • Total shares outstanding: According to the filing, 224,935,790 Class A shares were outstanding at the time of the notice.

Boughton's Proposed Transaction and Recent Sales History at Hims & Hers

According to the Form 144 filing submitted to the SEC on October 28, 2026, Soleil Boughton, identified as an officer of Hims & Hers Health, Inc. (NYSE:HIMS), proposed to sell 3,462 Class A common shares. The filing lists the approximate sale date as October 28, 2026, with Fidelity Brokerage Services LLC named as the executing broker. Hims & Hers Health is a telehealth and wellness company headquartered at 2269 Chestnut Street, San Francisco, California.

The 3,462 shares subject to this notice were acquired on August 15, 2026, through a restricted stock vesting event, with the issuer listed as the party from whom the shares were acquired. The nature of payment is described in the filing as compensation. The filing was signed by Jennifer Ruchti as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Boughton.

The filing also discloses five prior sales of Class A shares by Boughton during the three months preceding the notice. Those transactions, as reported, are: 25,111 shares sold on August 19, 2026, with gross proceeds of $691,808.05; 3,458 shares sold on September 2, 2026, with gross proceeds of $97,965.14; 6,236 shares sold on September 16, 2026, with gross proceeds of $173,734.96; 3,461 shares sold on September 30, 2026, with gross proceeds of $100,957.37; and 3,461 shares sold on October 14, 2026, with gross proceeds of $100,576.66. The filing indicates that the Rule 10b5-1 plan under which these sales are being made was adopted on May 21, 2026.

What Was Disclosed

The Form 144 notice discloses a proposed sale of 3,462 Class A shares of Hims & Hers Health, Inc. by officer Soleil Boughton, valued at $95,551.20, along with five prior sales during the preceding three months and the existence of a Rule 10b5-1 trading plan adopted May 21, 2026.